Smurfit-backed firm seeks €10m

24th September, 2017
Darren Cunningham, chief executive, and Dr Michael O’Neill, R&D manager, Inflection Biosciences

Company: Inflection Biosciences

Done deal: €2.5m investment

The clincher:“I am now actively engaging with a selection of new investors we would like to bring on board to help us transition through a VC-type investment” – Darren Cunningham, Inflection Biosciences

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Tom Maguire: Tax changes we make now could help business for years

More Business Tom Maguire 8 months ago

The Daily Briefing

The Daily Briefing